Summit Therapeutics Inc.
NASDAQ:SMMT · NASDAQ Global Market
+$0.19 today
Vol 7.26M · Avg 4.77M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-32.56%
Period High
$29.32
Period Low
$13.05
Latest
$13.75
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$33.54B
Moderna, Inc.
NASDAQ:MRNA
$24.52B
Royalty Pharma plc
NASDAQ:RPRX
$23.10B
Roivant Sciences Ltd.
NASDAQ:ROIV
$22.44B
Exact Sciences Corporation
EXAS
$20.03B
Ascendis Pharma A/S
NASDAQ:ASND
$14.36B
BridgeBio Pharma, Inc.
NASDAQ:BBIO
$13.20B
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
$12.28B
Universal Health Services, Inc.
NYSE:UHS
$8.84B
Atrium Therapeutics, Inc.
NASDAQ:RNA
$213.48M
What is the latest SMMT filing?
The latest filing shown is 8-K dated Jun 12, 2026.
How many recent filings does SMMT have?
Intrinsic Alpha currently shows 20 recent filings for SMMT.
Explore More
Continue the stock analysis
Jump to another research area for this company.